Revolutionising drug discovery with deep learning
Revolutionising drug discovery with deep learning
Europe PMC and Open Targets develop Lit-OTAR framework unearthing over 48 million unique associations that can be leveraged for drug discovery Identifying drug targets is a critical and intricate part of drug discovery. This requires scientists to look at many sources of evidence. They use them to find links between drugs, targets, and diseases. This […]
Partnerships & funding
Europe PMC is a service of the Europe PMC Funders' Group, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI); and in cooperation with the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NCBI/NLM) . It includes content provided to the PubMed Central (NLM/PMC) archive by participating publishers.
